Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Diatherix offers commercial molecular diagnostic testing panels using proprietary multiplex PCR technology to rapidly identify multiple pathogens and genetic resistance markers in clinical samples. Their tests are used by thousands of healthcare providers across the U.S., with results typically available within one day. The company has received FDA Emergency Use Authorization for COVID-related assays and has established partnerships to expand its test menu.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DIATHERAX.